8-Week Multimodal Trial Tests Gerotype-Personalized NMN, Urolithin A & Ergothioneine Stack
The PROMETHEUS feasibility trial enrolls 20 middle-aged-to-older adults in an 8-week multimodal intervention…
The PROMETHEUS feasibility trial enrolls 20 middle-aged-to-older adults in an 8-week multimodal intervention…
For the estimated 15–20% of older adults living with mild cognitive impairment, the question of who progresses to…
Mental health conditions collectively represent one of the largest sources of disability-adjusted life lost worldwide…
Every anti-aging intervention trial faces the same problem: how do you measure whether a treatment is actually slowing…
Knowing in advance whether a patient will respond to immunotherapy could spare them months of ineffective treatment…
For the roughly 300,000 people infected annually with Lassa virus across West Africa — and the travelers, healthcare…
For the millions of adults navigating cancer treatment, cardiovascular complications are already a leading cause of…
Most people accept muscle decline as an inevitable feature of aging, but new molecular evidence suggests that…
Understanding why humans live decades while fruit flies live weeks has challenged biologists for generations. A new…
For the roughly 30,000 Americans living with ALS at any given time, disease-modifying options remain desperately…
For the millions living with idiopathic pulmonary fibrosis — a progressive, largely untreatable scarring disease with…
For decades, exercise has been championed as the closest thing to an anti-aging intervention available to healthy…
For the roughly 50 million people worldwide living with Alzheimer's, Parkinson's, Huntington's disease, or ALS…
For clinicians and patients alike, mild stroke symptoms can create a dangerous sense of reassurance — yet for a…
For patients and clinicians who assume small strokes mean small consequences, a comprehensive review of subcortical…
Among 403,974 UK Biobank participants followed for 13+ years, high-risk liver fibrosis scores (NFS hazard ratio 1.54…
Applied to 278 patients hospitalized for acutely decompensated HFpEF (median age 75, 51.4% male), the AHA's PREVENT…
Using the CARDIOSIM numerical simulation platform, researchers modeled two configurations of the Impella RP right…
Among 1,022 probands with thoracic aortopathy assessed at a Canadian cardiac clinic between 2009 and 2024, only 43.5%…
Four weeks of dapagliflozin 10mg daily reduced resting peripheral venous pressure by 1.3 mmHg (p=0.012) in 26 adult…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.